Willem J Mulder, PhD
Willem Mulder, Ph.D., a biomedical engineer with a background in nanochemistry, is Professor of Radiology and Professor of Oncological Sciences at Icahn School of Medicine at Mount Sinai (ISMMS) in New York, as well as Professor of Precision Medicine at the Eindhoven University of Technology (TU/e), The Netherlands. Mulder obtained an M.Sc. in Chemistry from the Utrecht University (2001) and a Ph.D. in Biomedical Engineering from Eindhoven University of Technology (2006).
Mulder pioneered the exploitation of nanomaterials as highly tunable immunotherapeutics and molecular imaging agents. His research focuses on (nano-)immunotherapy and precision imaging in cardiovascular diseases, cancer and transplantation. Mulder established library technology, encompassing nanomaterials derived from natural lipoproteins (nanobiologics), that allows meticulously designing targeted immunotherapies. When appropriately designed, such nanobiologics can be applied to empower the immune system’s ability to fight disease, by promoting or inhibiting an immune response, by polarizing macrophage function, or by targeting myeloid cell dynamics.
Mulder has published more than 150 scientific publications in top scientific journals, including Nature Nanotechnology, Nature Reviews Drug Discovery, Nature Communications, Science Translational Medicine, Immunity, etc. His H-index is 62 and his work has been cited more than 11.000 times. Mulder is the principal investigator of multiple National Institutes of Health grants. In 2013, he received the Vidi grant, while in 2018 and the Vici grant from the Dutch Science Foundation (NWO).